CBD Life Sciences (OTCMKTS:CBDL) is gaining momentum in early trading on Monday.
As of 10.25, CBDL stock is trading lower by 12.50% at $0.0009. Volume was 414 million shares, well above its 3-day moving average volume of 291 million shares.
CBDL Issues News
This morning, CBD Life Sciences released news. Here are the key points to watch:
CBD Life Sciences, Inc. (CBDL) Launches Top Selling Pain Cream & Gummies on its Amazon Store
- CBDL announced the launch of two new products on its Amazon Store Located at www.amazon.com/shops/lbcbioscienceinc.
- The company wanted to introduce the addition of its Hemp-based product line on the shopping giant, Amazon.com, in a move that emphasizes the importance of hemp in the future of both LBC Bioscience Inc. and the nutritional hemp market which is “blowing up” around the world.
- CBD Life Sciences Inc. is very proud to showcase an addition of two more products on Amazon.
- These two products are the famous 1200MG Pain Relief Cream we have had on our e-commerce website for a very long time and the other product being the tasty yummy gummy bears coming in either 150MG or 350MG.
President & CEO Lisa Nelson states “We have been trying to get more and more products up on our Amazon Store and we will keep updating the shareholders as we go along!”
|SHARES OUTSTANDING||0.56 M|
|SHARE FLOAT (%)||–|
|% HELD BY INSTITUTIONS||51.79|
Recent Stock Performance
|+/- EMA(20)||0.0013 (-30.77%)|
|+/- SMA(50)||0.0021 (-57.14%)|
|+/- SMA(200)||0.0020 (-55.00%)|
|CCI20||-189.0411||Sell||Chaikin Money Flow||0.1499||Buy|
|MACD||-0.0007||Sell||Money Flow Index||21.1656||Buy|
|STOCH (14,3)||0.0000||OverSold||STOCH RSI||0.0000||OverSold|